Gene therapy increases survival for end-stage head and neck canc...

Courtesy EurekAlert! - Cancer  Tue, 05/27/2008 - 23:00

(University of Texas M. D. Anderson Cancer Center) A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a US phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.

Sponsors

 

Related items

Creating lung cancer risk models for specific populations...
(University of Texas M. D. Anderson Cancer Center) Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by...

M. D. Anderson study finds racial disparities in radiation...
(University of Texas M. D. Anderson Cancer Center) Black women are less likely than white women to receive radiation therapy after a lumpectomy, the...

M. D. Anderson study finds change in HER2 status after...
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when...

Faulty DNA repair could be a risk factor for lung cancer in...
(American Association for Cancer Research) People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at...

Metformin increases pathologic complete response rates in...
(University of Texas M. D. Anderson Cancer Center) Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com